Skip to main content

Peer Review reports

From: Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study

Original Submission
5 Dec 2019 Submitted Original manuscript
27 Dec 2019 Reviewed Reviewer Report - . Shalimar
3 Jan 2020 Reviewed Reviewer Report - Sunil Taneja
14 Jan 2020 Reviewed Reviewer Report - Kaushal Madan
11 Feb 2020 Author responded Author comments - Phunchai Charatcharoenwitthaya
Resubmission - Version 2
11 Feb 2020 Submitted Manuscript version 2
Publishing
17 Feb 2020 Editorially accepted
5 Mar 2020 Article published 10.1186/s12876-020-01196-0

You can find further information about peer review here.

Back to article page